1 Result(s)

Article

Appropriate dose of regorafenib based on body weight of colorectal cancer patients: a retrospective cohort study

Previous randomized studies have shown a survival benefit of using regorafenib but a high rate of adverse events in unresectable colorectal cancer patients. To reduce these adverse events and improve the toler...

Masayuki Nakashima, Kan Li, Qichen Chen, Sajith de Silva, Hal Li… in BMC Cancer (2023)